House Resolution Commemorating the Dobbs v. Jackson Decision

As the US Supreme Court reviews access to the abortion drug mifepristone, reproductive health advocates are preparing for a potential shift toward misoprostol-only abortion regimens. This article explores the history, medical function, and legal status of these medications in the context of current judicial and legislative challenges.

Supreme Court Justice Neil Gorsuch spoke to Fox News Digital about the dangers of violence against the judiciary and the importance of maintaining confidential internal deliberations. He emphasized that judicial independence relies on the ability of justices to debate candidly without external pressure or security threats.

A federal appeals court has halted a 2023 FDA rule that allowed the abortion medication mifepristone to be prescribed via telehealth and sent through the mail. The court ruled that the state of Louisiana is likely to succeed in its lawsuit challenging the FDA's decision-making process, citing concerns over safety data and state sovereignty.

Danco Laboratories has filed an emergency request with the U.S. Supreme Court to block a lower court ruling that restricts access to the abortion pill mifepristone. The company argues the ruling creates immediate confusion for patients and providers by banning mail-order access and requiring in-person visits.

A federal appeals court has temporarily reinstated an in-person requirement for obtaining the abortion medication mifepristone, effectively halting telemedicine prescriptions for the drug nationwide. The ruling blocks 2023 FDA rules that allowed providers to mail the medication to patients, though the decision is expected to face further appeals to the Supreme Court.